- Companies
- Laboratorio Farmaceutico
Laboratorio Farmaceutico Valuation Multiples
Laboratorio Farmaceutico is valued at $10M as of November 2026, a 1.0x revenue multiple. In the last 12 months, Laboratorio Farmaceutico revenue was $11M and Laboratorio Farmaceutico EBITDA was $2M.
Laboratorio Farmaceutico Overview
About Laboratorio Farmaceutico
Laboratorio Farmaceutico Erfo is an Italian nutraceutical company based in Villafranca Tirrena, Messina, listed on Euronext Growth Milan under the ticker ERFO. It is an innovative small and medium-sized enterprise and a benefit corporation that formulates, produces and packages food supplements, including contract manufacturing for third parties. The group also franchises retail networks in nutrition, wellness and fitness under the brands Dietnatural, BodySano and Fit&Go, with more than 250 points of sale in Italy and abroad. It also has a medical division, which more than doubled its revenue in the first half of 2026. For 2024 it reported consolidated revenues of EUR 6.2 million and adjusted EBITDA of EUR 1.4 million, with a net cash position of EUR 2.1 million. In the first half of 2026 revenues were EUR 5.3 million, up 2 percent, and adjusted EBITDA was EUR 1.3 million.
Founded
2013
HQ
Employees
33
Website
Sectors
Financials (LTM)
EV
$11M
Valuation Multiples
Start free trialLaboratorio Farmaceutico Financials
Laboratorio Farmaceutico reported last 12-month revenue of $11M and EBITDA of $2M.
In the same LTM period, Laboratorio Farmaceutico generated $2M in EBITDA and $831K in net income.
Revenue (LTM)
Laboratorio Farmaceutico P&L
In the most recent fiscal year, Laboratorio Farmaceutico reported revenue of $11M and EBITDA of $2M.
Laboratorio Farmaceutico is profitable as of last fiscal year, with gross margin of 70%, EBITDA margin of 20%, and net margin of 4%.
Financial data powered by Morningstar, Inc.
Laboratorio Farmaceutico Stock Performance
Laboratorio Farmaceutico has current market cap of $10M, and enterprise value of $11M.
Market Cap Evolution
Laboratorio Farmaceutico's stock price is $1.21.
Laboratorio Farmaceutico share price increased by 3.2% in the last 30 days, and decreased by 26.1% in the last year.
Laboratorio Farmaceutico has an EPS (earnings per share) of $0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11M | $10M | -0.5% | 3.2% | -9.3% | -26.1% | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLaboratorio Farmaceutico Valuation Multiples
Laboratorio Farmaceutico trades at 1.0x EV/Revenue multiple, and 4.6x EV/EBITDA.
EV / Revenue (LTM)
Laboratorio Farmaceutico Financial Valuation Multiples
As of November 8, 2026, Laboratorio Farmaceutico has market cap of $10M and EV of $11M.
Laboratorio Farmaceutico has a P/E ratio of 12.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Laboratorio Farmaceutico Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Laboratorio Farmaceutico Margins & Growth Rates
Laboratorio Farmaceutico decreased revenue by 1% but EBITDA grew by 5% in the last fiscal year.
In the most recent fiscal year, Laboratorio Farmaceutico reported gross margin of 70%, EBITDA margin of 20%, and net margin of 4%.
Laboratorio Farmaceutico Margins
Laboratorio Farmaceutico Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Laboratorio Farmaceutico Operational KPIs
Laboratorio Farmaceutico's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Laboratorio Farmaceutico's Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Laboratorio Farmaceutico's Rule of X is 19% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Laboratorio Farmaceutico Competitors
Laboratorio Farmaceutico competitors include Precision Peptide Co, Cartier Saada, MLK Foods, Ersu, Ecomiam, Cavitation Technologies, Kalve Coffee, Australian Dairy, Epsium Enterprise and New Nordic Healthbrands.
Most Laboratorio Farmaceutico public comparables operate across Food & Beverages.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $36K | ($3M) | 255.7x | - | (2.9x) | - | |||
| - | - | - | - | - | - | |||
| $141M | $5M | 0.6x | - | 17.7x | - | |||
| $3M | ($1M) | 2.6x | - | (7.9x) | - | |||
| $44M | ($3M) | 0.3x | 0.3x | (3.3x) | (7.3x) | |||
| $3K | ($1M) | 3384.3x | - | (7.4x) | - | |||
| $6M | $175K | 1.4x | - | 48.7x | - | |||
| $5M | ($2M) | 2.0x | - | (6.5x) | - | |||
This data is available for Pro users. Sign up to see all Laboratorio Farmaceutico competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Laboratorio Farmaceutico
Laboratorio Farmaceutico has acquired 2 companies to date.
Last acquisition by Laboratorio Farmaceutico was on December 30th 2024. Laboratorio Farmaceutico acquired Fit And Go for $5M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Laboratorio Farmaceutico
| Description | Milan-based Fit And Go operates a chain of 15 EMS gyms across Italy offering 20-minute electro-muscle stimulation sessions combined with bodyweight circuits and personal training. Each studio features Miha Bodytec suits delivering up to 30,000 muscle contractions per workout, certified by TÜV for safety. Founded in 2017, the franchise model expands to Rome and Turin locations with memberships starting at group classes tracked via proprietary app. | FRCM1 is an Italian company that owns the FarmaWoW portal, an e-commerce site in pharma and beauty with more than 43 thousand references in its catalogue. In the first six months of 2023 it reported revenues of about EUR 750,000 from about 12,000 orders, at an average order value of about EUR 68. Its EBITDA margin was about 3 percent and its net financial position was close to zero. It was owned by MP Holding S.r.l., traceable to Maria Palomba, until September 2023. After the sale Farmacosmo held 51 percent and Erfo 49 percent, and in December 2024 Farmacosmo bought the Erfo stake and took 100 percent. |
| HQ Country | ||
| HQ City | Rome | Naples |
| Deal Date | 30 Dec 2024 | 29 Sep 2023 |
| Valuation | $5M | $328K |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Laboratorio Farmaceutico acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Laboratorio Farmaceutico
| When was Laboratorio Farmaceutico founded? | Laboratorio Farmaceutico was founded in 2013. |
| Where is Laboratorio Farmaceutico headquartered? | Laboratorio Farmaceutico is headquartered in Italy. |
| How many employees does Laboratorio Farmaceutico have? | As of today, Laboratorio Farmaceutico has over 33 employees. |
| Is Laboratorio Farmaceutico publicly listed? | Yes, Laboratorio Farmaceutico is a public company listed on Borsa Italiana. |
| What is the stock symbol of Laboratorio Farmaceutico? | Laboratorio Farmaceutico trades under ERFO ticker. |
| When did Laboratorio Farmaceutico go public? | Laboratorio Farmaceutico went public in 2022. |
| Who are competitors of Laboratorio Farmaceutico? | Laboratorio Farmaceutico main competitors include Precision Peptide Co, Cartier Saada, MLK Foods, Ersu, Ecomiam, Cavitation Technologies, Kalve Coffee, Australian Dairy, Epsium Enterprise, New Nordic Healthbrands. |
| What is the current market cap of Laboratorio Farmaceutico? | Laboratorio Farmaceutico's current market cap is $10M. |
| What is the current revenue of Laboratorio Farmaceutico? | Laboratorio Farmaceutico's last 12 months revenue is $11M. |
| What is the current revenue growth of Laboratorio Farmaceutico? | Laboratorio Farmaceutico revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Laboratorio Farmaceutico? | Current revenue multiple of Laboratorio Farmaceutico is 1.0x. |
| What is the current EBITDA of Laboratorio Farmaceutico? | Laboratorio Farmaceutico's last 12 months EBITDA is $2M. |
| What is Laboratorio Farmaceutico's EBITDA margin? | Laboratorio Farmaceutico's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Laboratorio Farmaceutico? | Current EBITDA multiple of Laboratorio Farmaceutico is 4.6x. |
| What is the current FCF of Laboratorio Farmaceutico? | Laboratorio Farmaceutico's last 12 months FCF is $852K. |
| What is Laboratorio Farmaceutico's FCF margin? | Laboratorio Farmaceutico's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Laboratorio Farmaceutico? | Current FCF multiple of Laboratorio Farmaceutico is 12.7x. |
| How many companies Laboratorio Farmaceutico has acquired to date? | As of November 2026, Laboratorio Farmaceutico has acquired 2 companies. |
| What was the largest acquisition by Laboratorio Farmaceutico? | $5M acquisition of Fit And Go on 30th December 2024 was the largest M&A Laboratorio Farmaceutico has done to date. |
| What companies Laboratorio Farmaceutico acquired? | Laboratorio Farmaceutico acquired Fit And Go and FRCM1. |
| In how many companies Laboratorio Farmaceutico has invested to date? | Laboratorio Farmaceutico hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Laboratorio Farmaceutico
Lists including Laboratorio Farmaceutico
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




